LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...

08:14 AM EST, 02/17/2026 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Tuesday an independent data safety monitoring board has recommended for the fifth time continuation of a phase 3 study of its Bria-IMT plus an immune checkpoint inhibitor to treat metastatic breast cancer patients after reviewing safety data. The company said the board, which neets quarterly in accordance...

08:13 AM EST, 02/17/2026 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Tuesday that the Data Safety Monitoring Board (DSMB) has issued its fifth consecutive positive recommendation following review of safety data from BriaCell's Phase 3 study of Bria-IMT plus immune checkpoint inhibitor (CPI) in patients with metastatic breast cancer. The ongoing pivotal Phase 3 study is being conducted...

08:11 AM EST, 02/17/2026 (MT Newswires) -- Sherritt International ( SHERF ) said Tuesday that it has reduced operations at its Moa joint venture in Cuba due to fuel supply constraints affecting the country. The company said it expects to pause mining operations and place the processing plant on standby within the next week during which time, planned maintenance activities...